Abstarct Submission
Abstracts can be submitted in the following thematic areas
- Precision Medicine
- Genetics and Genomics
- Epigenetics and Mechanisms
- Nutrition and Epigenetics
- AI and ML in Cancer Diagnosis and Treatment
- Pharmaceutical agents Development and Delivery
- Cancer Biology and Cancer Stem Cells
- Molecular mechanisms of drugs
- Synthesis and Characterization of Anti-Cancer Agents
- Bioactivity-guided isolation and characterization of anti-cancer agents
- Alternate Models of Cancer
- Molecular Epidemiology of Cancer
- Molecular Docking
- Indian Ayurveda system in Cancer Therapy
- Prenatal Diagnosis of Cancer
- Cancer Nanotheranostics
Abstract Format
Abstract (250 words excluding title, authors and author affiliations, Font to be used in the abstract: Arial
- Title (Font size: 14 bold)
- Authors and affiliations (Font size: 12; Underline and bold the presenting author)
- Keywords- Minimum four keywords
- Corresponding author (Font size-12; Provide affiliation and contact details)
- Background
- Materials and Methods
- Results and Discussion
- Conclusions
- Last Date for Submission of Abstract: 15 th October 2025
Prior registration is mandatory to submit the abstract. *Abstract submissions after 30 th September 2025 till 15 th October 2025 are considered late submissions and will be subjected to additional registration fees as detailed in Late Registration (1 st October – 15th October 2025). No Abstract will be accepted after 15 th October 2025.
Abstracts can be submitted in the following thematic areas
- Precision Medicine
- Genetics and Genomics
- Epigenetics and Mechanisms
- Nutrition and Epigenetics
- AI and ML in Cancer Diagnosis and Treatment
- Pharmaceutical agents Development and Delivery
- Cancer Biology and Cancer Stem Cells
- Molecular mechanisms of drugs
- Synthesis and Characterization of Anti-Cancer Agents
- Bioactivity-guided isolation and characterization of anti-cancer agents
- Alternate Models of Cancer
- Molecular Epidemiology of Cancer
- Molecular Docking
- Indian Ayurveda system in Cancer Therapy
- Prenatal Diagnosis of Cancer
- Cancer Nanotheranostics
Abstract Format
Abstract (250 words excluding title, authors and author affiliations, Font to be used in the abstract: Arial
- Title (Font size: 14 bold)
- Authors and affiliations (Font size: 12; Underline and bold the presenting author)
- Keywords- Minimum four keywords
- Corresponding author (Font size-12; Provide affiliation and contact details)
- Background
- Materials and Methods
- Results and Discussion
- Conclusions
- Last Date for Submission of Abstract: 15 th October 2025
